DCF Advisers, LLC
- SEC CIK
- 0001802493
- Latest filing
- Aug 10, 2026
TEVA holding history
Teva Pharmaceutical Industries Ltd in every 13F filed by DCF Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings
- Shares (Q2 2026)
- 254,500
- Value
- $8.62M
- % of portfolio
- 2.3%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 254,500 | $8.62M | 2.3% | −45,500−15.2% | Reduced | Holders |
| Q1 2026 | 300,000 | $9.04M | 3.4% | −85,000−22.1% | Reduced | Holders |
| Q4 2025 | 385,000 | $12.0M | 4.0% | +17,300+4.7% | Added | Holders |
| Q3 2025 | 367,700 | $7.43M | 2.8% | +185,200+101.5% | Added | Holders |
| Q2 2025 | 182,500 | $3.06M | 1.5% | +11,500+6.7% | Added | Holders |
| Q1 2025 | 171,000 | $2.63M | 1.4% | +23,500+15.9% | Added | Holders |
| Q4 2024 | 147,500 | $3.25M | 1.6% | +34,500+30.5% | Added | Holders |
| Q3 2024 | 113,000 | $2.04M | 1.0% | −17,750−13.6% | Reduced | Holders |
| Q2 2024 | 130,750 | $2.12M | 1.1% | +45,750+53.8% | Added | Holders |
| Q1 2024 | 85,000 | $1.20M | 0.7% | +46,000+117.9% | Added | Holders |
| Q4 2023 | 39,000 | $407.2K | 0.3% | −5,500−12.4% | Reduced | Holders |
| Q3 2023 | 44,500 | $453.9K | 0.3% | +5,500+14.1% | Added | Holders |
| Q2 2023 | 39,000 | $293.7K | 0.2% | +39,000 | New | Holders |